Rockefeller Capital Management’s Bio-Path Holdings Inc BPTH Stock Holding History

Rockefeller Capital Management’s Portfolio BPTH Stock Details BPTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3	Closed	–	–	2858
2020 Q2	$0	Hold	3	–	–	﹤0.01%	2720
2020 Q1	$0	Hold	3	–	–	﹤0.01%	2516
2019 Q4	$0	Buy	+3	New	+$564	﹤0.01%	2247

Other funds holding BPTH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Human Investing Lake Oswego, Oregon $771M AUM 18.84% 1-Year Est. Return

Rockefeller Capital Management's BPTH Position: Q3 2020 in Review

Rockefeller Capital Management sold out of Bio-Path Holdings Inc (BPTH) in Q3 2020, closing a stake of 3 shares.

Rockefeller Capital Management first reported a position in BPTH in Q4 2019 and held it in 3 quarters. The position peaked at $0 in Q2 2020. 14 funds tracked by Wall St. Rank hold BPTH as of Q3 2020.

Rockefeller Capital Management reported no remaining Bio-Path Holdings Inc position as of Q3 2020 after selling out during the quarter.
Rockefeller Capital Management sold 3 Bio-Path Holdings Inc shares in Q3 2020.
Rockefeller Capital Management first reported a position in Bio-Path Holdings Inc in Q4 2019 and held it in 3 quarters.
Rockefeller Capital Management's Bio-Path Holdings Inc position peaked at $0 in Q2 2020.
14 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2020.

Based on Rockefeller Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.